■ Book and thesis
|
1.
|
2022/10
|
Article
|
High-Sensitivity and High-Throughput Quantification of Everolimus in Human Whole Blood Using Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry. Therapeutic drug monitoring 44(5),pp.633-640 (Collaboration)
|
|
2.
|
2022/08
|
Article
|
Chlorine Atoms of an Aripiprazole Molecule Control the Geometry and Motion of Aripiprazole and Deschloro-aripiprazole in Subdomain IIIA of Human Serum Albumin. ACS omega 7(34),pp.29944-29951 (Collaboration)
|
|
3.
|
2022/04
|
Article
|
Response to "iPTH is not a significant factor influencing the tacrolimus C/D ratio". Clinical and translational science 15(4),pp.807-808 (Collaboration)
|
|
4.
|
2022/02
|
Article
|
Effects of Myristate on the Induced Circular Dichroism Spectra of Aripiprazole Bound to Human Serum Albumin: A Structural-Chemical Investigation. ACS omega 7(5),pp.4413-4419 (Collaboration)
|
|
5.
|
2021/11
|
Article
|
The Binding of Aripiprazole to Plasma Proteins in Chronic Renal Failure Patients. Toxins 13(11) (Collaboration)
|
|
6.
|
2021/09
|
Article
|
Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal disease. Clinical and translational science 14(5),pp.2034-2042 (Collaboration)
|
|
7.
|
2020/07
|
Article
|
Effect of Cinacalcet on the Redox Status of Albumin in Secondary Hyperparathyroidism Patients Receiving Hemodialysis. Biological & pharmaceutical bulletin 43(10),pp.1583-1590 (Collaboration)
|
|
8.
|
2019/01
|
Article
|
Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule. Biological & pharmaceutical bulletin 42(5),pp.786-791 (Collaboration)
|
|
9.
|
2017/12
|
Article
|
Parathyroid hormone contributes to the down-regulation of cytochrome P450 3A through the cAMP/PI3K/PKC/PKA/NF-κB signaling pathway in secondary hyperparathyroidism. Biochemical pharmacology 145,pp.192-201 (Collaboration)
|
|
10.
|
2015/02
|
Article
|
Polythiol-containing, recombinant mannosylated-albumin is a superior CD68+/CD206+ Kupffer cell-targeted nanoantioxidant for treatment of two acute hepatitis models. The Journal of pharmacology and experimental therapeutics 352(2),pp.244-57 (Collaboration)
|
|
11.
|
2014/10
|
Article
|
Possible false-negative results on therapeutic drug monitoring of phenytoin using a particle enhanced turbidimetric inhibition immunoassay in a patient with a high level of IgM. Therapeutic drug monitoring 36(5),pp.553-5 (Collaboration)
|
|
12.
|
2010/07
|
Article
|
Genetically engineered mannosylated-human serum albumin as a versatile carrier for liver-selective therapeutics. Journal of controlled release : official journal of the Controlled Release Society 145(1),pp.9-16 (Collaboration)
|
|
13.
|
2005/05
|
Article
|
CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells. Journal of biochemistry 137(5),pp.607-16 (Collaboration)
|
|
Display 5 items
|
|
Display all(13)
|
|
■ Academic background
|
■ Business career
|
■ researchmap Researcher code
|
■ Qualification and license
|
■ E-Mail Address
|
■ Present specialized field
|
■ Department laboratory expense researcher number
|
